HAYLIE TRAN: Open Payments
NPI 1225764459 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,942 in 109 payments from 40 companies in 2025. Trend: 2023 $1,593 · 2024 $2,182 · 2025 $2,942
Food & beverage: $2,842Education: $100
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $311 |
| Novartis Pharmaceuticals Corporation | 12 | $298 |
| Daiichi Sankyo Inc. | 8 | $198 |
| E.R. Squibb & Sons, L.L.C. | 9 | $167 |
| Genentech USA, Inc. | 5 | $164 |
| Eisai Inc. | 5 | $132 |
| Incyte Corporation | 4 | $107 |
| ABBVIE INC. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $103 |
| SEAGEN INC. | 1 | $100 |
Products named: OPDIVO, KEYTRUDA, Enhertu, Lenvima, Fabhalta, FRUZAQLA, IMFINZI, PLUVICTO.
Industry payments across CA — which companies pay providers there.
